Table 1.
F- D3 RMS (n=24) |
|
---|---|
Original histology assignment | |
Embryonal RMS | 19 (79%) |
Spindle cell RMS | 3 (13%) |
Botryoid RMS | 1 (4%) |
Alveolar RMS | 0 (0%) |
RMS NOS | 1 (4%) |
Age at diagnosis | |
≤ 1year | 3 (13%) |
1–10 years | 12 (50%) |
10–21 years | 9 (37%) |
Gender | |
Female | 8 (33%) |
Male | 16 (67%) |
Primary site | |
Genitourinary | 11 (46%) |
Head/neck | 8 (33%) |
Extremities | 0 (0%) |
Other | 5 (21%) |
IRS stage | |
Stage 1 | 7 (29%) |
Stage 2 | 7 (29%) |
Stage 3 | 8 (33%) |
Stage 4 | 2 (8%) |
IRS group | |
Group I | 7 (29%) |
Group II | 4 (17%) |
Group III | 11 (46%) |
Group IV | 2 (8%) |
IRS risk | |
Low | 12 (50%) |
Intermediate | 10 (42%) |
High | 2 (8%) |
Primary tumor size | |
≥5cm | 15 (63%) |
<5cm | 9 (37%) |